Epinephrine News and Research

RSS

Study links COVID-19 to multisystem inflammatory syndrome in children

At the height of the COVID-19 pandemic in April, a 14-year-old boy was admitted to the emergency department at Nemours Children's Health System in Delaware with mysterious symptoms in what would later be identified as one of the first cases of multisystem inflammatory syndrome in children (MIS-C) in the U.S.

10 Sep 2020

Common asthma drug may offer potential as treatment for Alzheimer's disease

A new study reveals that the common asthma drug salbutamol may offer potential as a treatment for Alzheimer's disease.

1 Jul 2020

New drug can prevent life-threatening anaphylaxis, shows study

For someone with a food or drug allergy, the risk of life-threatening anaphylactic shock lurks around every corner. A new Northwestern Medicine study shows there might be a pill that can be taken proactively to prevent mild to life-threatening anaphylaxis, no matter the cause.

3 Jun 2020

Study finds potential under-diagnosis of food allergy among Medicaid-enrolled children

Prevalence of food allergy among Medicaid-enrolled children across the U.S. was substantially lower (0.6 percent), compared to previous national estimates using parent surveys (7.6 percent) and reports of physician confirmation of food allergy (4.7 percent).

13 May 2020

Transferring knowledge, not anxiety, can help food-allergic children cope with their fears

A new article in Annals of Allergy, Asthma and Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology discusses the difficulties faced by parents of children with food allergies in not transferring their own anxieties to their children.

25 Feb 2020

FDA approves first oral immunotherapy treatment for peanut allergy in children, teens

The University of Chicago Medicine was part of a landmark clinical trial that led to approval by the U.S. Food and Drug Administration of the first oral immunotherapy treatment for peanut allergy in children and teens.

13 Feb 2020

P53-deficient oral cancers recruit and reprogram nerves to fuel tumor growth

Loss of an important tumor-suppressing gene allows head and neck cancer to spin off signals to nearby nerves, changing their function and recruiting them to the tumor, where they fuel growth and cancer progression, researchers from The University of Texas MD Anderson Cancer Center report in the journal Nature today.

13 Feb 2020

Epiglottitis linked to teenager's use of e-cigarettes

A teenage girl with no hint of prior asthma or respiratory illness began to feel hoarseness in her throat and a feeling that she needed to clear her throat frequently.

5 Feb 2020

FDA-approved OIT product marks major milestone in management of peanut allergies

In February 2020, the U.S. Food and Drug Administration (FDA) approved Palforzia, the first peanut powder product designed to help reduce the risk of severe peanut-induced allergic reactions through desensitization over time.

4 Feb 2020

Study finds stress does whiten hair

In most cases, hair starts to gray in the thirties, and becomes pronounced in the fifties, at which time the head is typically crowned with a thatch of white, gray and perhaps some hair of the original color. A new study published January 2020 in the journal Nature, shows that this process is speeded up significantly by acute stress persisting over a period, or by severe trauma.

22 Jan 2020

UMN and Windgap Medical collaborate to design cyanide antidote autoinjector

The University of Minnesota Twin Cities and Windgap Medical have received a $3.2 million grant from the National Institutes of Health to develop a new device to quickly administer a recently developed antidote for cyanide poisoning.

14 Jan 2020

Researchers evaluate epinephrine use for treatment of pediatric OHCA

A loved one suffering cardiac arrest is an emotionally stressful time for families, but never more so than when the patient is a child. The very real potential for loss of life in these situations means that the way in which emergency responders treat out of hospital cardiac arrest (OHCA) becomes even more crucial when dealing with pediatric patients.

14 Jan 2020

Recommendations to help manage five common holiday-related stressors

Although the holiday season can be a time for joy, fun, and family, it is also common for people to feel overwhelmed or experience temporary anxiety, stress, or sadness.

19 Nov 2019

New treatment stops peanut allergy for 6 weeks with single dose

A small study published in the journal JCI Insight on November 14, 2019, suggests that antibody treatment could help people with severe allergy to peanuts eat a small amount of peanut-containing food just two weeks later, without any ill effects. This seems to show that this is a safe, fast and effective treatment for food allergy.

14 Nov 2019

Risk factors of malignant arrhythmias found in patients treated with therapeutic hyperthermia after cardiac arrest

Researchers showed that 20-50% of patients developed an irregular heartbeat that required defibrillation during the active cooling phase of therapeutic hypothermia following an out-of-hospital cardiac arrest.

5 Nov 2019

Cleveland Clinic announces Top 10 Medical Innovations for 2020

A dual-acting osteoporosis drug. Minimally invasive mitral valve surgery. New treatment for peanut allergies. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of doctors and researchers.

23 Oct 2019